← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Proteios Technology, Inc.
Issaquah, WA
$4,553,962
Total funding
6
Grants
Funding over time
peak $1.8M · FY2018–23$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,378,963 · 4
NSF$1,174,999 · 2
By mechanism
R44$1,595,090 · 1
—$1,174,999 · 2
N44$1,049,979 · 1
N43$455,000 · 1
R43$278,894 · 1
Investigators at Proteios Technology, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING$1,049,979
N44 · FY2023 · CA
SBIR Phase II: Removing the Purification Bottleneck in Biopharmaceutical Production$949,999
· FY2020 · TIP
Simple and Effective Method for Cell Separation During Preclinical Research and Cell Therapy Manufacturing$816,395
R44 · FY2022 · GM
Simple and Effective Method for Cell Separation During Preclinical Research and Cell Therapy Manufacturing$778,695
R44 · FY2023 · GM
TOPIC 429 - A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING (SBIR)$400,000
N43 · FY2021 · CA
SBIR Phase I: Removing the Purification Bottleneck in Biopharmaceutical Production$225,000
· FY2018 · TIP
Simple and Effective Method for Cell Enrichment and Cell Depletion During Cell Therapy$223,894
R43 · FY2019 · GM
TOPIC 429 - A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING (SBIR)$55,000
N43 · FY2022 · CA
Simple and Effective Method for Cell Enrichment and Cell Depletion During Cell Therapy$55,000
R43 · FY2020 · GM